Recruiting NA Alcohol Abuse

New treatment option for Alcohol Abuse

Official title Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption

ClinicalTrials.gov ID: NCT06247306

What this study is testing

What it's testing
In this research project, the aim is to discover the role specific brain networks play in the relationship between stress reactions and the desire for alcohol and alcohol consumption. To investigate this question, various brain imaging methods as well as cognitive tasks are combined.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • Age 18-65 years
  • Presence of 2 to a maximum of 5 criteria for alcohol use disorder according to DSM-5
  • no clinical necessity for detoxification treatment
  • participants may have a moderate cannabis use disorder and tobacco use disorder
  • Capacity for consent and ability to use self-assessment scales

You likely can't join if

  • Lifetime diagnosis of bipolar or psychotic disorder or a substance use disorder according to Diagnostical and Statistical Manual of Mental Disorders...
  • Current substance use other than cannabis and tobacco
  • Current diagnosis of one of the following conditions according to DSM-5: (hypo)manic episode, major depression, generalized anxiety disorder...
  • History of severe head trauma or other severe central neurological disorders (dementia, Parkinson\'s disease, multiple sclerosis)
  • Pregnancy or lactation
  • Use of medications known to interact with the central nervous system within the last 10 days; testing at least four half-lives after the last dose
See the full eligibility criteria
Who can join
  • Age 18-65 years
  • Presence of 2 to a maximum of 5 criteria for alcohol use disorder according to DSM-5
  • no clinical necessity for detoxification treatment
  • participants may have a moderate cannabis use disorder and tobacco use disorder
  • Capacity for consent and ability to use self-assessment scales
  • Sufficient knowledge of German
  • Willingness to use a mobile phone with Android operating system
What rules you out
  • Lifetime diagnosis of bipolar or psychotic disorder or a substance use disorder according to Diagnostical and Statistical Manual of Mental Disorders - 5 (DSM-5) that is not alcohol, cannabis, or tobacco use disorder
  • Current substance use other than cannabis and tobacco
  • Current diagnosis of one of the following conditions according to DSM-5: (hypo)manic episode, major depression, generalized anxiety disorder, post-traumatic stress disorder, borderline personality disorder, or...
  • History of severe head trauma or other severe central neurological disorders (dementia, Parkinson\'s disease, multiple sclerosis)
  • Pregnancy or lactation
  • Use of medications known to interact with the central nervous system within the last 10 days; testing at least four half-lives after the last dose
  • Exercising the prerogative of the \"Right not to know\" in the context of incidental findings during an examination or investigation

The study team makes the final eligibility decision.

Where it's taking place

  • Mannheim, Baden-Wurttemberg, Germany

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Mannheim, Baden-Wurttemberg, Germany. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.